CA
NZ
UK
AU
IND
US
…
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Heart Test Laboratories Inc. is a small publicly traded company whose filings indicate it provides medical laboratory services focused on cardiovascular diagnostics. Long-term growth drivers may include rising demand for cardiac testing and scaling laboratory capacity, and investors may find the company attractive for exposure to a niche diagnostics provider benefiting from demographic-driven healthcare demand.
Key risks include limited public disclosure and financial transparency, small market capitalization with low liquidity, dependence on regulatory approvals and reimbursement, and competition from established diagnostics firms.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
| Income before tax | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M |
| Net income | -9.14M | -8.77M | -6.61M | -490.85M | -4.58M |
| Selling general administrative | 9.94M | 3.97M | 3.44M | 3.65M | 1.71M |
| Gross profit | -0.13M | -0.13M | -0.08M | 0.00M | 0.01M |
| Reconciled depreciation | 0.13M | 0.13M | 0.10M | 0.03M | 0.03M |
| Ebit | -16.36M | -8.35M | -6.25M | -6.11M | -4.71M |
| Ebitda | -8.41M | -8.22M | -6.16M | -6.08M | -4.68M |
| Depreciation and amortization | 32.57M | 0.13M | 0.10M | 0.03M | 0.03M |
| Operating income | -8.41M | -8.35M | -6.31M | -6.11M | -4.71M |
| Other operating expenses | 8.42M | 8.36M | 6.32M | 6.12M | 4.72M |
| Interest expense | 0.75M | 0.50M | 0.35M | 0.24M | 0.37M |
| Net interest income | -0.75M | -0.50M | -0.35M | -0.24M | -0.37M |
| Income tax expense | -3.68M | - | -0.10M | 484.50M | -0.25M |
| Total revenue | 0.00M | 0.00M | 0.02M | 0.01M | 0.01M |
| Total operating expenses | 8.28M | 8.23M | 6.22M | 6.12M | 4.72M |
| Cost of revenue | 0.13M | 0.13M | 0.10M | 0.00M | 0.01M |
| Total other income expense net | -0.73M | -0.41M | -0.30M | -0.24M | -0.12M |
| Net income from continuing ops | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M |
| Net income applicable to common shares | - | - | - | -6.35M | -4.83M |
| Breakdown | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
| Total assets | 5262.67M | 4.22M | 9.50M | 3.29M | 2.09M |
| Intangible assets | 2372.37M | 1.62M | 1.59M | - | - |
| Other current assets | 270.49M | 0.42M | 0.92M | 0.04M | 0.04M |
| Total liab | 5036.61M | 4.02M | 2.19M | 3.06M | 8.15M |
| Total stockholder equity | 225.53M | 0.21M | 7.32M | 0.23M | -6.06M |
| Other current liab | 781.64M | 0.71M | 0.70M | 0.05M | 1.05M |
| Common stock | 3.19M | 0.00M | 0.00M | 0.01M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M |
| Retained earnings | -85269.51M | -76.13M | -67.36M | -60.76M | -54.40M |
| Other liab | - | - | - | 0.19M | 0.23M |
| Good will | - | - | -1587.66M | - | - |
| Cash | 1656.81M | 1.10M | 5.81M | 1.66M | 0.92M |
| Total current liabilities | 4861.11M | 3.70M | 1.75M | 1.83M | 3.47M |
| Current deferred revenue | - | - | 0.67M | 0.62M | - |
| Net debt | 2279.83M | 1.89M | -4.77M | -0.09M | 5.24M |
| Short term debt | 3761.15M | 2.67M | 0.60M | 0.53M | 1.72M |
| Short long term debt | 3.62M | 2.55M | 0.50M | 0.50M | 1.63M |
| Short long term debt total | 3936.65M | 2.99M | 1.04M | 1.57M | 6.16M |
| Other stockholder equity | 85491.47M | 76.33M | 74.68M | 61.36M | 48.34M |
| Property plant equipment | - | - | - | 0.59M | 0.16M |
| Total current assets | 2582.93M | 2.17M | 7.35M | 2.70M | 1.93M |
| Net tangible assets | - | - | - | 0.23M | -6.06M |
| Net receivables | 0.00M | 0.00M | 0.88M | 0.32M | 0.00M |
| Long term debt | - | - | - | 0.50M | 4.44M |
| Inventory | 655.63M | 0.65M | 0.63M | 0.68M | 0.67M |
| Accounts payable | 318.33M | 0.32M | 0.45M | 0.63M | 0.69M |
| Accumulated other comprehensive income | - | - | -0.38M | -0.38M | - |
| Non current assets total | 2679.74M | 2.05M | 2.15M | 0.59M | 0.16M |
| Capital lease obligations | 0.31M | 0.43M | 0.54M | 0.57M | 0.09M |
| Breakdown | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
| Investments | - | -0.03M | -0.13M | -0.02M | -0.00M |
| Change to liabilities | - | - | - | 0.04M | 0.36M |
| Total cashflows from investing activities | -0.04M | -0.03M | -0.13M | -0.02M | -0.00M |
| Net borrowings | 2.31M | 1.59M | 0.04M | -0.40M | 4.23M |
| Total cash from financing activities | 8.03M | 2.73M | 10.34M | 6.53M | 3.84M |
| Change to operating activities | - | - | - | 0.14M | 0.69M |
| Net income | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M |
| Change in cash | 0.56M | -4.71M | 4.15M | 0.74M | 0.19M |
| Begin period cash flow | 1.10M | 5.81M | 1.66M | 0.92M | 0.72M |
| End period cash flow | 1.66M | 1.10M | 5.81M | 1.66M | 0.92M |
| Total cash from operating activities | -7.43M | -7.41M | -6.07M | -5.77M | -3.64M |
| Issuance of capital stock | 5.72M | 1.15M | 10.30M | 5.62M | 0.00M |
| Depreciation | 0.13M | 0.13M | 0.10M | 0.03M | 0.03M |
| Other cashflows from investing activities | -0.04M | -0.03M | -0.06M | - | - |
| Change to inventory | -0.01M | -0.02M | 0.05M | -0.00M | 0.08M |
| Change to account receivables | 0.00M | -0.00M | 0.00M | 0.00M | -0.00M |
| Other cashflows from financing activities | 5.55M | - | -0.13M | 1.31M | -551.43M |
| Change to netincome | - | - | - | 0.32M | -0.12M |
| Capital expenditures | 0.04M | 0.03M | 0.13M | 0.02M | 0.00M |
| Change in working capital | -1.08M | 0.52M | -0.50M | 0.17M | 1.12M |
| Stock based compensation | 1.31M | 0.25M | 0.41M | 0.25M | 0.07M |
| Other non cash items | 1.35M | 0.46M | 0.54M | -100.97M | -0.04M |
| Free cash flow | -7.47M | -7.44M | -6.20M | -5.79M | -3.65M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HSCS Heart Test Laboratories Inc. Common Stock |
-0.30 8.31% |
3.31 | - | - | 3654.04 | 70.85 | 4353.17 | -0.14 |
| ABT Abbott Laboratories |
1.63 1.56% |
106.20 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.57 0.59% |
96.54 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-19.89 6.38% |
291.86 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
-0.11 0.22% |
47.69 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
| Name | Title | Year Born |
|---|---|---|
| Mr. Andrew Simpson | CEO, Pres & Chairman of Directors | 1969 |
| Ms. Danielle Watson | CFO & Treasurer | 1982 |
| Mr. Mark T. Hilz | COO, Sec. & Director | 1959 |
| Mr. Andrew Simpson | CEO, President & Chairman of the Board of Directors | 1970 |
| Ms. Danielle Watson | CFO & Treasurer | 1983 |
| Mr. Mark T. Hilz | COO, Secretary & Director | 1959 |
| Mr. Andrew Simpson | CEO, President & Chairman of the Board of Directors | 1969 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...